Literature DB >> 29216637

ILUVIEN in Diabetic Macular Edema: The Choice of Second-Line Corticosteroid Should Be Left to the Clinical Judgement of the Treating Physician.

John Hall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29216637     DOI： 10.1159/000481157

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


× No keyword cloud information.
  1 in total

1.  The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.

Authors:  Sara Vaz-Pereira; João Paulo Castro-de-Sousa; David Martins; Joaquim Prates Canelas; Pedro Reis; António Sampaio; Helena Urbano; Paulo Kaku; João Nascimento; Carlos Marques-Neves
Journal:  Ophthalmic Res       Date:  2019-12-04       Impact factor: 2.892
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.